This protocol describes specific steps for analyzing the behavior of CD8+ T and myeloid cells in human ex vivo slices of high-grade serous ovarian cancer omental biopsies, shortly after resection and up to 24 h after slicing, providing the opportunity for treatment of the slices. Here, CD8A is linked to ovarian serous adenocarcinoma.